Trial intelligence / Profile preview

Neoadjuvant Cisplatin and Irinotecan in Locally Advanced Cervical Cancer

NCT04789941Phase 2Unknown

Sponsor
Assiut University
Start
Apr 2021
Primary completion
Dec 2021
Modality
Small Molecules
01

Overview

A Phase 2 trial of irinotecan in Cervical Cancer (CC), sponsored by Assiut University. Status: unknown.

02

Drugs

irinotecan
03

Conditions

Cervical Cancer (CC)

Beyond the preview

Go deeper on NCT04789941.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04789941.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call